Burrows Scott L: insider trades.
Burrows Scott L reported 13 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 10 sales ($3.7M), across 1 company.
- Transactions
- 13
- Purchases (P)
- 0
- Sales (S)
- 10
- Companies
- 1
- Name as filed
- Burrows Scott L
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | Officer · Chief Financial Officer | 13 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-02 | Spyre Therapeutics, Inc. | S | 18,232 | $89.35 | 79,762 | Form 4 |
| 2026-09-01 | Spyre Therapeutics, Inc. | S | 200 | $89.04 | 97,994 | Form 4 |
| 2026-09-01 | Spyre Therapeutics, Inc. | S | 2,016 | $88.03 | 98,194 | Form 4 |
| 2026-09-01 | Spyre Therapeutics, Inc. | S | 900 | $86.25 | 104,594 | Form 4 |
| 2026-09-01 | Spyre Therapeutics, Inc. | S | 4,384 | $87.11 | 100,210 | Form 4 |
| 2026-09-01 | Spyre Therapeutics, Inc. | M | 7,500 | $14.5 | 105,494 | Form 4 |
| 2026-08-03 | Spyre Therapeutics, Inc. | S | 2,300 | $96.3 | 98,094 | Form 4 |
| 2026-08-03 | Spyre Therapeutics, Inc. | S | 5,100 | $95.21 | 100,394 | Form 4 |
| 2026-08-03 | Spyre Therapeutics, Inc. | M | 7,500 | $14.5 | 105,494 | Form 4 |
| 2026-08-03 | Spyre Therapeutics, Inc. | S | 100 | $97.1 | 97,994 | Form 4 |
| 2026-07-01 | Spyre Therapeutics, Inc. | S | 5,775 | $87.55 | 99,719 | Form 4 |
| 2026-07-01 | Spyre Therapeutics, Inc. | S | 1,725 | $88.37 | 97,994 | Form 4 |
| 2026-07-01 | Spyre Therapeutics, Inc. | M | 7,500 | $14.5 | 105,494 | Form 4 |
Questions
What stock did Burrows Scott L buy or sell?
Burrows Scott L reported 13 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 10 sales ($3.7M), across 1 company.
Is Burrows Scott L the same person as other filers with this name?
This page covers SEC CIK 1853327 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/burrows-scott-l-1853327.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.